Private EquityRIA · CRD 290447Exempt Reporting AdviserPrivate Fund Adviser

Updated:

M33 Growth

M33 seeks to partner with ambitious bootstrapped entrepreneurs by providing both capital and resources to accelerate growth and develop their already-great...

M33 Growth logo

M33 Growth

M33 seeks to partner with ambitious bootstrapped entrepreneurs by providing both capital and resources to accelerate growth and develop their already-great businesses into market leaders. The firm intentionally builds a concentrated portfolio so that each company is not a small fish in a big pond, with its next investment #19 as the active lead. Its world revolves around its portfolio companies.

General information

Firm type

Private Equity

Year founded

2017

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Principals

Michael Anello

Co-Founder & Managing Director

Brian Shortsleeve

Co-Founder & Managing Director

Gabriel Ling

Co-Founder & Managing Director

Sector focus

Enterprise SoftwareDigital HealthAI/MLFinTech

Frequently asked questions

Who founded M33 Growth and what is their background?

The firm was founded in 2017 by Michael Anello, Brian Shortsleeve, and Gabriel Ling. Anello and Shortsleeve previously held senior roles focused on growth-stage operational investing. The team brought together a hybrid of private equity execution and hands-on operating expertise, positioning M33 as a commercial-scale partner rather than a passive growth-capital provider.

Does M33 Growth participate in early-stage venture rounds or only growth-stage deals?

M33 Growth almost exclusively targets revenue-stage companies generating $10 million to $75 million in annual recurring revenue. The firm does not run a seed or Series A practice. Its model is designed to acquire majority positions in bootstrapped or lightly capitalized businesses that have established product-market fit and need go-to-market execution.

How does M33 Growth source its portfolio companies?

The firm uses a proprietary outbound sourcing model concentrated on founder-owned software and digital health companies. M33 specifically targets businesses outside the coastal venture hubs — particularly in the Midwest and Southeast — that have grown without institutional capital. The partnership pool runs shared origination, and the firm often engages founders through direct conversations about liquidity and scaling, rather than through competitive auction processes.

Is M33 Growth a venture capital firm or a private equity firm?

M33 Growth is structured as a private equity firm that operates with a growth-buyout mandate. It acquires majority control in cash-flowing software companies, a posture closer to traditional growth equity with operating influence than to venture capital. The firm embeds sales and revenue operations resources into its portfolio to drive post-close execution.

What investment stages does M33 Growth typically target?

M33 Growth targets growth-stage and growth-buyout opportunities. The firm writes checks ranging from roughly $30 million to over $100 million per platform, focusing on companies with product-market fit and recurring revenue between $10 million and $75 million. It does not participate in early-stage or pre-revenue venture rounds.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Boston Private Equity profiles